treatment options - United States News Beep

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

August 20, 2026

Teva Pharmaceutical Industries Ltd Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA…

HHealth care

WHO warns global cancer cases could nearly double by 2050

July 8, 2026

The World Health Organization (WHO) said on Wednesday that the number of new cancer cases diagnosed worldwide each…

HHealth

College Student Fell Down Steps at School and Thought She Had a Concussion. Then, She Got a Shocking Diagnosis

March 21, 2026

NEED TO KNOW A woman discovered she had a brain tumor after a fall at her college led…

MMedication

Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

December 8, 2025

Geron Corporation Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target…